Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Choosing the right ACE inhibitor. A guide to selection

G Leonetti1, C Cuspidi

  • 1Istituto Scientifico Ospedale S. Luca, Università degli Studi, Milan, Italy.

Drugs
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Sudden death after facial impacts: Is the brainstem involved?" [Morphologie 106 (2022) 217-223].

Morphologie : bulletin de l'Association des anatomistes·2024
Same author

Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
Same author

Sudden death after facial impacts: Is the brainstem involved?

Morphologie : bulletin de l'Association des anatomistes·2021
Same author

Effect of surgical treatment on myocardial strain in patients with pheochromocytoma and paraganglioma: a mini-review and meta-analysis.

Journal of endocrinological investigation·2021
Same author

Combined use of postmortem 3D computed tomography reconstructions and 3D-design software for postmortem ballistic analysis.

Diagnostic and interventional imaging·2017
Same author

Forensic use of the Greulich and Pyle atlas: prediction intervals and relevance.

European radiology·2016

Selecting ACE inhibitors for hypertension involves considering pharmacokinetic factors like half-life and elimination route. Some ACE inhibitors, like lisinopril, show superior blood pressure reduction based on trough-to-peak ratios, particularly with ambulatory monitoring.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Arterial hypertension is a significant global health concern.
  • Angiotensin-Converting Enzyme (ACE) inhibitors are a cornerstone therapy for hypertension.
  • Patient selection among various ACE inhibitors requires understanding their pharmacokinetic and pharmacodynamic profiles.

Purpose of the Study:

  • To identify criteria for guiding the selection of ACE inhibitors in treating arterial hypertension.
  • To review pharmacokinetic and pharmacodynamic aspects of commonly used ACE inhibitors.

Main Methods:

  • Review of principal pharmacokinetic and pharmacodynamic aspects of frequently used ACE inhibitors.
  • Analysis of terminal half-life, route of elimination, and antihypertensive effect duration.

Related Experiment Videos

  • Evaluation of antihypertensive efficacy, including trough-to-peak blood pressure reduction ratios.
  • Assessment of effects on left ventricular hypertrophy and insulin resistance.

    • Main Results:

    • Terminal half-life and route of elimination are key pharmacokinetic factors influencing ACE inhibitor selection.
    • Antihypertensive efficacy is generally similar, but trough-to-peak ratios vary; lisinopril, enalapril, and trandolapril show higher ratios.
    • ACE inhibitors are highly effective in reducing left ventricular hypertrophy and may improve insulin resistance, with these effects appearing class-related.

    Conclusions:

    • Clinical selection of ACE inhibitors can be guided by pharmacokinetic properties like half-life and elimination.
    • The trough-to-peak ratio is a critical pharmacodynamic parameter, suggesting preference for certain ACE inhibitors (e.g., lisinopril, enalapril, trandolapril) for sustained blood pressure control.
    • While ACE inhibitors offer significant benefits for left ventricular hypertrophy and insulin resistance, these advantages appear to be class-wide rather than specific to individual agents.